HKSE:02185 (China)
Â
Class H
HK$
2.305
-0.055 (-2.33%)
Aug 12
Business Description
Shanghai Bio-heart Biological Technology Co Ltd
ISIN : CNE100004JH3
Share Class Description:
HKSE:02185: Class HTotal Employee Number:
65Compare
Compare
Traded in other countries / regions
02185.Hong Kong IPO Date
2021-12-23Description
Shanghai Bio-heart Biological Technology Co Ltd is engaged in the research and development of bioresorbable scaffold (BRS) products and the renal denervation (RDN) system. The company is a interventional cardiovascular device company in China, and locate in Shanghai Zhangjiang Hi-Tech Park Medical Device Industrial Park. Focused on two therapies, bioresorbable scaffolds (BRS) and renal denervation (RDN), addressing the unmet medical needs of Chinese patients for the treatment of coronary and peripheral artery diseases and uncontrolled hypertension. Currently, the portfolio has three product candidates in various stages of clinical development.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 19.52 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.19 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -0.09 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 31.1 | |||||
3-Year EPS without NRI Growth Rate | 34.7 | |||||
3-Year FCF Growth Rate | 24.1 | |||||
3-Year Book Growth Rate | -21.3 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 57.38 | |||||
9-Day RSI | 50.85 | |||||
14-Day RSI | 47.95 | |||||
3-1 Month Momentum % | -37.24 | |||||
6-1 Month Momentum % | -54.12 | |||||
12-1 Month Momentum % | -34.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 15.26 | |||||
Quick Ratio | 13.97 | |||||
Cash Ratio | 9.93 | |||||
Days Inventory | 330.44 | |||||
Days Sales Outstanding | 121.98 | |||||
Days Payable | 10.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | -1.12 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 40.06 | |||||
Operating Margin % | -154.04 | |||||
Net Margin % | -156.03 | |||||
EBITDA Margin % | -154.13 | |||||
FCF Margin % | -168.2 | |||||
OCF Margin % | -151.13 | |||||
ROE % | -13.54 | |||||
ROA % | -8.68 | |||||
ROIC % | -8.93 | |||||
3-Year ROIIC % | 400.83 | |||||
ROC (Joel Greenblatt) % | -52.78 | |||||
ROCE % | -11.19 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 11.35 | |||||
PB Ratio | 1.17 | |||||
Price-to-Tangible-Book | 3.07 | |||||
EV-to-EBIT | -5.16 | |||||
EV-to-EBITDA | -6.52 | |||||
EV-to-Revenue | 10.04 | |||||
EV-to-FCF | -5.97 | |||||
Earnings Yield (Greenblatt) % | -19.38 | |||||
FCF Yield % | -14.81 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Bio-heart Biological Technology Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 49.394 | ||
| EPS (TTM) (HK$) | -0.32 | ||
| Beta | 0.8221 | ||
| 3-Year Sharpe Ratio | 0.04 | ||
| 3-Year Sortino Ratio | 0.08 | ||
| Volatility % | 118.81 | ||
| 14-Day RSI | 47.95 | ||
| 14-Day ATR (HK$) | 0.266882 | ||
| 20-Day SMA (HK$) | 2.38525 | ||
| 12-1 Month Momentum % | -34.22 | ||
| 52-Week Range (HK$) | 1.82 - 10.77 | ||
| Shares Outstanding (Mil) | 243.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Bio-heart Biological Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Bio-heart Biological Technology Co Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Bio-heart Biological Technology Co Ltd Frequently Asked Questions
What is Shanghai Bio-heart Biological Technology Co Ltd(HKSE:02185)'s stock price today?
The current price of HKSE:02185 is HK$2.31. The 52 week high of HKSE:02185 is HK$10.77 and 52 week low is HK$1.82.
When is next earnings date of Shanghai Bio-heart Biological Technology Co Ltd(HKSE:02185)?
The next earnings date of Shanghai Bio-heart Biological Technology Co Ltd(HKSE:02185) is .
Does Shanghai Bio-heart Biological Technology Co Ltd(HKSE:02185) pay dividends? If so, how much?
Shanghai Bio-heart Biological Technology Co Ltd(HKSE:02185) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Shanghai Bio-heart Biological Technology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers